Thoratec (NSDQ:THOR) said today it won CE Mark approval in the European Union for its HeartMate percutaneous heart pump. Approval was based on data from the 1st 30 patients enrolled in its Shield I CE mark trial, the Pleasanton, Calif.-based company said. Data from all 50 patients in the study is slated to be presented later this […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Edwards Lifesciences to drop $400m on CardiAQ Valve
Edwards Lifesciences (NYSE:EW) last week said it agreed to pay $400 million for CardiAQ Valve Technologies and its transcatheter mitral valve implant, saying it also reached a deal to revise the protocol for restarting a trial of its own Fortis mitral valve. The deal for CardiAQ Valve, which like Edwards is based in Irvine, Calif., calls for an up-front […]
CryoLife BioGlue wins expanded indication in Japan
CryoLife Inc. (NYSE:CRY) said yesterday that it won expanded indications from the Japanese Pharmaceuticals and Medical Device Agency for its BioGlue surgical adhesive. The glue is now indicated for use in adhesion and support of hemostasis for aortotomy closure sites, suture and anastomosis sites (including aortic dissection and prosthetic grafts) and heart suture sites, the […]
UPDATE: Jury finds against Boston Scientific in $200m spat with stent pioneer Jang
UPDATED July 9, 2015, with correction of Law360 report, Boston Scientific comments. A California jury today opened the door to a potential $200 million decision for Boston Scientific (NYSE:BSX) in a long-running royalties dispute with coronary stent pioneer Dr. David Jang, finding that the company infringed a patent and breached its licensing deal with Jang, according to Law360, which originally reported that […]
Biotronik launches CRT in women study
Biotronik said last week it enrolled the 1st patient in its Biowomen study investigating the difference in cardiac resynchronization therapy response in men and women to understand if women respond better to the treatment. The trial seeks to enroll 247 patients of each gender over 2 years, with a 1-year follow-up and results expected in 2018, the […]
Biotronik launches Itrevia MRI-safe quad CRT-D in Japan
Biotronik said today that it launched its Itrevia MRI-safe quad cardiac resynchronization therapy defibrillator in Japan, part of a Japanese rollout of new devices for 2015. The device is equipped with home monitoring connectivity, as well as compatibility with up to 1.5 tesla MRI machines, the German medical device giant said. “As a producer of superior […]
Toshiba, Merge ink partnership deal
Merge Healthcare (NSDQ:MRGE) said yesterday it formed a strategic partnership with Toshiba Medical Systems (TYO:6502) to offer both companies products together as a turnkey solution for customers. The companies will partner to offer Merge’s cardiology PACS and hemodynamic monitoring with the Toshiba vascular x-ray systems, Chicago, Ill.-based Merge Healthcare said. “For more than 15 years, the Toshiba […]
St. Jude Medical launches OCT stenting trial
St. Jude Medical (NYSE:STJ) today said it’s launching the 1st trial comparing optical coherence tomography device with intravascular ultrasound or angiography during stenting procedures. St. Paul, Minn.-based St. Jude said the 420-patient Ilumien III trial will compare treatment with its Optis Integrated and Ilumien Optis percutaneous coronary intervention optimization systems in treating patients with stable or unstable angina, silent ischemia or […]
UPDATE: Medical societies update stroke guidelines
A bevy of cardiac medical societies updated their guidelines for stroke treatment yesterday to take into account new devices and technology, including left atrial appendage occlusion devices, stent retrievers and thrombectomy devices. The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions have updated their guidelines to include the benefits of left […]
AHA/ASA updates stroke treatment guidelines
The American Heart Association/American Stroke Association said today that it updated its treatment guidelines for patients suffering from ischemic stroke to include endovascular treatments. The decision supports the use of stent retrieval, and other thrombectomy devices, used to remove clots in patients who have obstructions in the large arteries supplying blood to the brain according […]
DoJ closes Abiomed Impella 2.5 investigation
Abiomed (NSDQ:ABMD) said today that the U.S. Department of Justice has closed an investigation into the marketing of the company’s Impella 2.5 heart pump without taking any enforcement action. The investigation began in October 2012 when Danvers, Mass.-based Abiomed said it was informed that the U.S. Attorney’s Office of the District of Columbia had initiated […]